Dr. Hearn Jay Cho is an associate professor of medicine at the Icahn School of Medicine at Mount Sinai and an attending physician with the multiple myeloma service at the Mount Sinai Tisch Cancer Institute in New York. He is also the chief medical officer of the Multiple Myeloma Research Foundation. His laboratory investigates novel therapies for multiple myeloma in two areas: the interaction between myeloma and the immune system in the tumor microenvironment to better personalize immunotherapies for cancer patients, and melanoma antigen genes that are correlated with disease progression and play a critical role in treatment resistance. His team is currently conducting studies to identify novel pharmacologic strategies to inhibit these genes in myeloma. Dr. Cho received his M.D. and Ph.D. in immunology from Cornell University Medical College and did his clinical fellowship in Hematology and Medical Oncology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.